Clinical Trial Site

Alicante 03203

3 studies enrolling now · 4 studies all time

What they study most

Acid Cholesteryl Ester Hydrolase Deficiency, Type 2, Acid Lipase Deficiency, Advanced Breast Cancer, Breast Cancer, Cholesterol Ester Storage Disease, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, LAL-Deficiency, LIPA Deficiency

Studies at this site

• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• Lysosomal Acid Lipase (LAL) Deficiency Registry — Recruiting now
• A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery — Completed